Di Bernardo et al. (2008) have hypothesised that in CLL, the causal allelic variant increases risk by arresting the IRF4-dependent transition of memory B cells into plasma cells. The gene discussed is IRF4; the disease is B-cell chronic lymphocytic leukemia.